Skip to main content

Table 3 Multivariate analysis for prognostic factors

From: Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification

Subject

HR

CI 95%

P value

OS

 Age

0.331

0.160–0.683

0.003

 Tumor size

0.262

0.098–0.699

0.007

 EQD2(point A)

2.530

1.159–5.521

0.036

DFS

 Age

0.462

0.232–0.920

0.028

 EFI

1.927

1.000–3.714

0.050

 EQD2(point A)

2.949

1.379–6.306

0.005

LCR

 Tumor size

0.091

0.011–0.745

0.026

 Age

0.266

0.084–0.843

0.024

 EQD2(point A)

5.578

1.795–17.332

0.003

OFRFS

 Concurrent chemotherapy

2.738

1.248–6.009

0.012

 EFI

3.287

1.369–7.892

0.008